Pictet Asset Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Buy
352,428
+38,918
+12% +$1.7M 0.02% 537
2025
Q4
$12.2M Sell
313,510
-62,539
-17% -$2.38M 0.01% 635
2025
Q3
$13.3M Sell
376,049
-110,091
-23% -$3.99M 0.01% 611
2025
Q2
$17.5M Buy
486,140
+120,930
+33% +$4.01M 0.02% 540
2025
Q1
$11.4M Buy
365,210
+38,838
+12% +$1.23M 0.01% 623
2024
Q4
$8.33M Sell
326,372
-16,036
-5% -$425K 0.01% 713
2024
Q3
$9.67M Sell
342,408
-7,340
-2% -$203K 0.01% 662
2024
Q2
$9.22M Sell
349,748
-254,997
-42% -$7.07M 0.01% 643
2024
Q1
$18.4M Sell
604,745
-113,167
-16% -$3.34M 0.02% 507
2023
Q4
$20.2M Buy
717,912
+57,416
+9% +$1.58M 0.02% 490
2023
Q3
$17.9M Buy
+660,496
New +$19.6M 0.02% 484

Other funds holding RPRX